Metagenomi Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.08 M | $1.28 M | 1.87% | 2.86% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 742.40 K | $883.46 K | -5.77% | 1.97% |
| CATALIO CAPITAL MANAGEMENT, LP | 08/14/2026 | 528.99 K | $629.50 K | 0.00% | 1.40% |
| PEAPOD LANE CAPITAL LLC | 07/27/2026 | 525.02 K | $624.78 K | 1.60% | 1.39% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 513.70 K | $611.30 K | 3.41% | 1.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 400.30 K | $476.36 K | 1.14% | 1.06% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 379.51 K | $451.61 K | 87.75% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 288.67 K | $343.67 K | -19.41% | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 08/13/2026 | 264.39 K | $314.63 K | 0.00% | 0.70% |
| BLACKROCK, INC. | 08/07/2026 | 257.63 K | $306.58 K | 11.95% | 0.68% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 171.25 K | $203.79 K | 0.63% | 0.45% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 160.00 K | $190.40 K | -58.13% | 0.42% |
| STATE STREET CORP | 08/07/2026 | 119.85 K | $142.62 K | -0.48% | 0.32% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 114.03 K | $135.69 K | -32.97% | 0.30% |
| MAN GROUP PLC | 08/14/2026 | 109.13 K | $129.87 K | 38.78% | 0.29% |
| RESOLUTE ADVISORS LLC | 08/14/2026 | 89.94 K | $107.03 K | 0.00% | 0.24% |
| MARQUETTE ASSET MANAGEMENT, LLC | 07/09/2026 | 72.12 K | $85.82 K | 100.00% | 0.19% |
| NORTHERN TRUST CORP | 08/13/2026 | 68.94 K | $82.04 K | -8.29% | 0.18% |
| RBF CAPITAL, LLC | 08/14/2026 | 64.02 K | $76.19 K | 0.00% | 0.17% |
| XTX TOPCO LTD | 08/14/2026 | 55.71 K | $66.29 K | 37.27% | 0.15% |
| BBR PARTNERS, LLC | 08/11/2026 | 53.40 K | $63.55 K | 0.00% | 0.14% |
| JANE STREET GROUP, LLC | 08/14/2026 | 38.40 K | $45.69 K | -74.65% | 0.10% |
| FORTITUDE ADVISORY GROUP L.L.C. | 07/22/2026 | 37.19 K | $44.26 K | 0.00% | 0.10% |
| CITADEL ADVISORS LLC | 09/02/2026 | 17.85 K | $21.24 K | 5.05% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 16.85 K | $20.05 K | 100.00% | 0.04% |
| UBS GROUP AG | 08/13/2026 | 15.79 K | $18.79 K | -1.89% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 15.17 K | $18.06 K | 100.00% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 13.39 K | $15.94 K | 0.00% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 12.80 K | $15.23 K | 0.00% | 0.03% |
| PEAK PLANNING GROUP, LLC | 08/12/2026 | 12.50 K | $14.88 K | 0.00% | 0.03% |
| MEEDER ASSET MANAGEMENT INC | 08/07/2026 | 5.50 K | $6.54 K | 0.00% | 0.01% |
| MORGAN STANLEY | 08/13/2026 | 5.30 K | $6.31 K | -80.77% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 5.30 K | $6.31 K | 12,519.05% | 0.01% |
| US BANCORP \DE\ | 08/12/2026 | 4.50 K | $5.36 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 1.89 K | $2.25 K | -34.59% | 0.01% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.60 K | $1.92 K | 0.00% | 0.00% |
| FMR LLC | 08/13/2026 | 588 | $700 | -87.54% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 500 | $625 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 08/11/2026 | 500 | $595 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 207 | $246 | -32.57% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 167 | $199 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 8 | $10 | 100.00% | 0.00% |
| OPTIVER HOLDING B.V. | 08/12/2026 | 2 | $2 | -88.89% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 08/10/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 0 | $0 | -100.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Metagenomi Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 61 institutional investors and hedge funds held shares of Metagenomi Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD CAPITAL MANAGEMENT LLC: 1.08 M
RENAISSANCE TECHNOLOGIES LLC: 742,400
Catalio Capital Management, LP: 528,993
Peapod Lane Capital LLC: 525,024
TWO SIGMA INVESTMENTS, LP: 513,701
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 400,300
16.63% of Metagenomi Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 9.15 M shares in the last 24 months. This purchase volume represents approximately $14.63 M in transactions.